The purpose of this study is to compare the effects of nasal and oronasal interfaces during ASV treatment on sleep efficiency and sleep architecture. Therefore, patients starting treatment with ASV, will be randomized between two groups. In the first group, patients will use a nasal interface during the first night and an oronasal interface during the second night. In the second group, patients will use an oronasal mask first and a nasal mask during the second night. The results of this trial will have major impact on future clinical practice as it would deliver prediction rules to choose the correct interface immediately.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
15
One night of ASV treatment with oronasal mask followed by one night of ASV treatment with nasal mask.
One night of ASV treatment with nasal mask followed by one night of ASV treatment with oronasal mask.
UZ Leuven
Leuven, Belgium
RECRUITINGApnea/hypopnea index
Effect on respiratory events
Time frame: Two nights
Mask comfort VAS
Subjective mask comfort
Time frame: Two nights
Device leaks data
Evaluation of leaks (data of ASV device)
Time frame: Two nights
Sleep efficiency
polysomnographic evaluation
Time frame: Two nights
Sleep architecture
Polysomnographic evaluation of different sleep stages
Time frame: Two nights
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.